Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease

Background: We evaluated the erythropoietic effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, in type 2 diabetes patients with anemia of chronic kidney disease. Methods: Nine diabetes patients were enrolled and administered 100 mg canagliflozin once a day for 12 weeks. The patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Technol Ther
Main Authors: Maruyama, Takashi, Takashima, Hiroyuki, Oguma, Hidetaka, Nakamura, Yoshihiro, Ohno, Michiko, Utsunomiya, Kei, Furukawa, Tetsuya, Tei, Ritsukou, Abe, Masanori
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875696/
https://ncbi.nlm.nih.gov/pubmed/31385724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2019.0212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados